Durdyeva E D, Kukushkina G V, Gorbacheva K B
Biull Eksp Biol Med. 1986 Feb;101(2):192-5.
The damage of DNA structure and synthesis in murine leukemia L1210 cells upon single administration in therapeutic doses of antitumour agents of N-nitrosourea type, such as 1-methyl-1-nitrosourea (MNU) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) was studied. MNU and BCNU were characterized by stronger inhibitory effects on de novo DNA synthesis compared to additional pathway of DNA synthesis in leukemia L1210 cells in vivo. Centrifugation in alkaline sucrose density gradients of L1210 cell lysates has revealed persistent single-strand breaks and alkaline-labile sites in newly replicated DNA. Parental DNA structure was more stable to damaging drug effects than that of newly replicated DNA. The results are consistent with our previous data on the differences in the mechanisms of MNU and BCNU action and the absence of complete cross resistance between the drugs.
研究了在治疗剂量下给予N-亚硝基脲类抗肿瘤药物(如1-甲基-1-亚硝基脲(MNU)和1,3-双(2-氯乙基)-1-亚硝基脲(BCNU))单次给药后,对小鼠白血病L1210细胞DNA结构和合成的损伤。与体内白血病L1210细胞DNA合成的其他途径相比,MNU和BCNU对DNA从头合成具有更强的抑制作用。对L1210细胞裂解物进行碱性蔗糖密度梯度离心,结果显示新复制的DNA中存在持续的单链断裂和碱不稳定位点。亲本DNA结构比新复制的DNA结构对损伤药物的作用更稳定。这些结果与我们之前关于MNU和BCNU作用机制差异以及药物之间不存在完全交叉耐药性的数据一致。